LUPI, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 341
EU - Europa 82
AS - Asia 39
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 1
Totale 482
Nazione #
US - Stati Uniti d'America 340
IT - Italia 34
IE - Irlanda 25
SG - Singapore 20
SE - Svezia 19
CI - Costa d'Avorio 15
CN - Cina 15
IN - India 4
MA - Marocco 4
GB - Regno Unito 2
CA - Canada 1
DE - Germania 1
EU - Europa 1
GR - Grecia 1
Totale 482
Città #
Des Moines 76
Chandler 64
New York 28
Boardman 25
Ashburn 23
Dublin 23
Abidjan 15
Fairfield 15
Turin 10
Singapore 9
Lawrence 7
Princeton 7
Wilmington 6
San Mateo 5
Washington 5
Arnold 4
Pune 4
San Diego 4
Seattle 4
Santa Clara 3
Woodbridge 3
Ancona 2
Ann Arbor 2
Cambridge 2
Fabriano 2
Guangzhou 2
Wuhan 2
Andover 1
Centro 1
Dallas 1
Fermignano 1
Foshan 1
Houston 1
Islington 1
Los Angeles 1
Mantova 1
Milan 1
Naples 1
Quanzhou 1
Shenzhen 1
Somerville 1
Tolentino 1
Toronto 1
Wuxi 1
Totale 369
Nome #
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab 71
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 67
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 65
Seroprevalence of SARS-CoV-2-Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy 63
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer 59
Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis 56
Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab 40
Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study 24
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 21
The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives 21
Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers 10
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 6
Totale 503
Categoria #
all - tutte 3.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.598


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 5 0 12 6
2021/202259 0 5 0 3 0 5 1 0 14 2 14 15
2022/2023232 13 23 8 15 6 90 0 9 35 6 24 3
2023/2024126 19 4 8 6 16 50 1 3 0 4 1 14
2024/202563 44 19 0 0 0 0 0 0 0 0 0 0
Totale 503